Epithelium, dendritic cells, and Clostridium difficile associated colitis
Epithelium, dendritic cells, and Clostridium difficile associated colitis
批准号:
8402524
负责人:
Hanping Feng
金额:
$19.46万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2015-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Clostridium difficile, an etiologic agent for pseudomembranous colitis, accounts for a quarter cases of antibiotic-associated diarrhea. With the recent emergence of hypervirulent strains, the incidence of C. difficile infection (CDI) has increased significantly in both North America and Europe, causing lengthy hospitalization, substantial morbidity and mortality. CDI is thought to be mainly mediated by exotoxins TcdA and TcdB, which glucosylate low molecular mass GTPase of the Rho family, leading to massive fluid secretion, acute inflammation, and necrosis of the colonic mucosa. Our long-term goal is to understand the mechanisms mediating intestinal inflammation in C. difficile infection and to utilize this knowledge for the design of better immune interventions in order to reduce the incidence of CDI and severity of the disease. The interaction of intestinal epithelial cells (IECs) with intestinal antigen presenting cells (APCs), such as dendritic cells (DCs) and macrophages, in the gut orchestrates mucosal immune homeostasis and inflammatory response. Our objective is to elucidate the immune response of IECs and intestinal DCs after their exposure to C. difficile toxins and to determine the nature of their interaction on initiating intestinal inflammation and tissue destruction. To achieve this objective, we will test several working hypotheses: 1) C. difficile toxin-intoxicated IECs are capable of mobilizing and activating DCs; 2) In severe cases of CDI, C. difficile toxins can cross a severely damaged intestinal barrier and further activate DCs and macrophages; and 3) proinflammatory cytokine TNF-a synergizes with the toxins to induce apoptosis of IECs, thus exacerbating tissue destruction and enterocolitis. By testing these hypotheses, we expect to gain a better understanding of not only the underlying mechanisms by which C. difficile toxins induce severe enterocolitis, but also the role of IEC-DC interaction in the onset and development of intestinal inflammatory diseases in general. We believe that such an understanding will help us to design better immune interventions against CDI and other intestinal inflammatory diseases.
PUBLIC HEALTH RELEVANCE: Clostridium difficile is the most common cause of hospital-acquired antibiotic-associated diarrhea and the etiologic agent of pseudomembranous colitis, the most severe intestinal inflammation. The diseases are in mainly caused by toxins secreted by the bacteria. The goal of this project is to elucidate the immune response of the intestinal epithelial cells (the first line of cells encountering the toxins) and intestinal dendritic cells (the immune cells regulating intestinal inflammatory response) after their exposure to C. difficile toxins and to determine the nature of their interaction on initiating intestinal inflammation and tissue destruction. We believe the study will help us to design better immune interventions against C. difficile infection and other intestinal inflammatory diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of neutralizing antitoxins and epitopes in Clostridium difficile patients
-
批准号:10549285
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2020
-
负责人:Hanping Feng
-
依托单位:
Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies
-
批准号:10540345
-
项目类别:
-
资助金额:$61.13万
-
财政年份:2020
-
负责人:Hanping Feng
-
依托单位:
Preventing norovirus and Clostridium difficile gastroenteritis by engineered probiotic yeast Saccharomyces boulardii secreting multi-specific single-domain antibodies
-
批准号:10320907
-
项目类别:
-
资助金额:$60.86万
-
财政年份:2020
-
负责人:Hanping Feng
-
依托单位:
Characterization of neutralizing antitoxins and epitopes in Clostridium difficile patients
-
批准号:10319522
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2020
-
负责人:Hanping Feng
-
依托单位:
Probiotic yeast secreting single-domain antibodies to prevent Clostridium difficile and Campylobacter jejuni disease
-
批准号:10364713
-
项目类别:
-
资助金额:$41.86万
-
财政年份:2019
-
负责人:Hanping Feng
-
依托单位:
Probiotic yeast secreting single-domain antibodies to prevent Clostridium difficile and Campylobacter jejuni disease
-
批准号:10584482
-
项目类别:
-
资助金额:$63.57万
-
财政年份:2019
-
负责人:Hanping Feng
-
依托单位:
A Novel Humanized Tetra-specific Antibody against Clostridium difficile Infection
-
批准号:10432036
-
项目类别:
-
资助金额:$100.87万
-
财政年份:2017
-
负责人:Hanping Feng
-
依托单位:
A Novel Humanized Tetra-specific Antibody against Clostridium difficile Infection
-
批准号:9362547
-
项目类别:
-
资助金额:$146.06万
-
财政年份:2017
-
负责人:Hanping Feng
-
依托单位:
Toxemia and systemic disease in Clostridium difficile infection
-
批准号:8664002
-
项目类别:
-
资助金额:$38.8万
-
财政年份:2013
-
负责人:Hanping Feng
-
依托单位:
Epithelium, dendritic cells, and Clostridium difficile associated colitis
-
批准号:7887611
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Development of Vaccines against Clostridium difficile Infection
-
批准号:7903007
-
项目类别:
-
资助金额:$66.39万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Epithelium, dendritic cells, and Clostridium difficile associated colitis
-
批准号:8064406
-
项目类别:
-
资助金额:$13.86万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Development of Vaccines against Clostridium difficile Infection
-
批准号:8648989
-
项目类别:
-
资助金额:$63.14万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Epithelium, dendritic cells, and Clostridium difficile associated colitis
-
批准号:8278048
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Development of Vaccines against Clostridium difficile Infection
-
批准号:8242822
-
项目类别:
-
资助金额:$63.95万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Development of Vaccines against Clostridium difficile Infection
-
批准号:8060479
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Epithelium, dendritic cells, and Clostridium difficile associated colitis
-
批准号:8661167
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Development of Vaccines against Clostridium difficile Infection
-
批准号:8458155
-
项目类别:
-
资助金额:$59.45万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Epithelium, dendritic cells, and Clostridium difficile associated colitis
-
批准号:8461668
-
项目类别:
-
资助金额:$30.43万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
Development of Vaccines against Clostridium difficile Infection
-
批准号:8409017
-
项目类别:
-
资助金额:$30.03万
-
财政年份:2010
-
负责人:Hanping Feng
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
-
批准号:82371801
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:周海波
-
依托单位:
缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
-
批准号:82370751
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张明
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
智障模型小鼠中树突棘可塑性的在体研究
-
批准号:81100839
-
项目类别:青年科学基金项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:李威
-
依托单位:
Wnt/β-catenin信号调控耐受型DC与根尖周骨破坏
-
批准号:81170956
-
项目类别:面上项目
-
资助金额:51.0万元
-
批准年份:2011
-
负责人:彭彬
-
依托单位:
浆细胞性树突状细胞在COPD发病机制中的作用及其对Treg的影响
-
批准号:81070032
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:陈雪芹
-
依托单位:
吲哚胺2,3双加氧酶抑制移植排斥反应的作用机制研究
-
批准号:81070377
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:戴向晨
-
依托单位:
Jagged2high CD11bhigh 调节性树突状细胞防治cGVHD的实验研究
-
批准号:30972790
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2009
-
负责人:杜欣
-
依托单位:
警报素(alarmin)HMGN1作为DNA疫苗佐剂的应用基础研究
-
批准号:30901376
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2009
-
负责人:魏枫
-
依托单位:
Endoglin基因修饰肿瘤/DC杂交细胞诱生靶向特异性抗人肺癌CTL疫苗的研究
-
批准号:30760248
-
项目类别:地区科学基金项目
-
资助金额:16.0万元
-
批准年份:2007
-
负责人:周源
-
依托单位: